Search results for query: *

Daval International Ltd. Is conducting an open label study in the United Kingdom which will examine the benefits of AIMSPRO, a novel therapy intended to treat those suffering with Amyotrophic lateral sclerosis (ALS) - also known as Lou Gehrig’s disease or Motor Neurones Disease. Daval...

Daval International are seeking 10 patients to participate in a new ALS clinical study in the U.K.